Xinquan Lan

Prevalence and Determinants of COVID-19 Vaccination Uptake Were Different between Chinese Diabetic Inpatients with and without Chronic Complications: A Cross-Sectional Survey

Zixin Wang, Ying Wang, Jing Li, 2022, Vaccines.

Uptake of Heterologous or Homologous COVID-19 Booster Dose and Related Adverse Events Among Diabetic Patients: A Multicenter Cross-Sectional Study — China, 2022

X. Chen, Jianzhou Yang, Yaxin Zhu, 2023, China CDC weekly.

The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study

Ying Yan, Yuxiao Wang, Xiangjun Zhang, 2023, Frontiers in Immunology.

The effectiveness of the first dose COVID-19 booster vs. full vaccination to prevent SARS-CoV-2 infection and severe COVID-19 clinical event: a meta-analysis and systematic review of longitudinal studies

Xiangjun Zhang, Junjie Xu, Jiaye Liu, 2023, Frontiers in Public Health.

Low uptake of COVID-19 booster doses among elderly cancer patients in China: A multicentre cross-sectional study

Junjie Xu, Xinquan Lan, Moxin Song, 2024, Journal of global health.

Willingness of people living with HIV to receive a second COVID-19 booster dose: a multicenter cross-sectional study in China

Yuxiao Wang, Ying Qiao, Junjie Xu, 2023, Frontiers in public health.